RecruitingNCT02877706

French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia


Sponsor

University Hospital, Toulouse

Enrollment

1,500 participants

Start Date

Jun 1, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

CARMEN is a national, real-world clinical registry of all adult patients with incident diagnosis of Immune thrombocytopenia (ITP) or Autoimmune Hemolytic anemia (AIHA) patients in France. It is aimed at describing ITP and AIHA clinical features, assessing the real-world risk-benefit ratio of treatments and adherence to guidelines for ITP and AIHA management.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying no specific intervention for people with autoimmune hemolytic anemia and immune thrombocytopenia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERno specific intervention

Locations(1)

Service de Médecine Interne

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02877706


Related Trials